Research Paper Volume 15, Issue 9 pp 3572—3585
Increased SEMA6B expression as a potential prognostic and immune cell infiltration biomarker in thyroid cancer patients
Figure 3. (A) Kaplan-Meier curve indicating overall survival comparison between THCA patient subgroup with high/ low SEMA6B mRNA expression; (B–H) Overall Survival comparison between THCA Patients Subgroup with SEMA6B high/low expression, patient subgroups were divided by TNM stages (B, C), Pathologic stages (D, E), Primary tumor focus type (F), Extra thyroidal extension (G, H) (n=502).